Literature DB >> 1281956

Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation.

G M Halliday1, H L McCann, R Pamphlett, W S Brooks, H Creasey, E McCusker, R G Cotton, G A Broe, C G Harper.   

Abstract

The location and number of brain stem serotonin-synthesizing neurons were analyzed in 11 patients with Alzheimer's disease (AD) and 5 age-matched controls using immunohistochemical techniques. In addition, the number of neuritic plaques and neurofibrillary tangles in the cortex and brain stem raphe was evaluated, as was the number of Nissl-stained raphe neurons. AD patients could be classified into two groups based on their raphe pathology; patients with such pathology (AD+) and those without (AD-). The number of large raphe neurons correlated significantly with the number of serotonin-synthesizing neurons in control material, indicating that all large neurons were serotonergic. This relationship was not apparent in AD+ patients, in whom the number of serotonin-synthesizing neurons correlated with the number of neurofibrillary tangles in the raphe of these patients. This indicates that in AD+ patients the serotonin-synthesizing neurons were selectively affected. There was no correlation between raphe and cortical pathology or raphe pathology and patient sex, age, mini-mental score or depression score, even when such scores were weighted for the interval between testing and death. There was a trend for the raphe pathology to correlate with the age of onset and duration of dementia and the Blessed dementia score in AD+ patients. Most AD+ patients with severe raphe lesions had clinical dementia only, while AD- patients had additional clinical features. The raphe lesions were more dramatic in AD+ patients with a rapid progression of symptoms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281956     DOI: 10.1007/BF00227741

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  63 in total

1.  5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue.

Authors:  J M Barnes; N M Barnes; B Costall; R J Naylor; M B Tyers
Journal:  Nature       Date:  1989-04-27       Impact factor: 49.962

2.  Cytoarchitecture of the human dorsal raphe nucleus.

Authors:  K G Baker; G M Halliday; I Törk
Journal:  J Comp Neurol       Date:  1990-11-08       Impact factor: 3.215

3.  Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus.

Authors:  K G Baker; G M Halliday; J P Hornung; L B Geffen; R G Cotton; I Törk
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

4.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

5.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

6.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

7.  5-Hydroxytryptamine and dopamine in pre-senile and senile Alzheimer-type dementia.

Authors:  C M Yates; J Simpson; A Gordon
Journal:  Biochem Soc Trans       Date:  1990-06       Impact factor: 5.407

8.  Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease.

Authors:  G M Halliday; P C Blumbergs; R G Cotton; W W Blessing; L B Geffen
Journal:  Brain Res       Date:  1990-02-26       Impact factor: 3.252

9.  Correlative decrease of large neurons in the neostriatum and basal nucleus of Meynert in Alzheimer's disease.

Authors:  K Oyanagi; H Takahashi; K Wakabayashi; F Ikuta
Journal:  Brain Res       Date:  1989-12-18       Impact factor: 3.252

10.  The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy.

Authors:  D M Mann; B Marcyniuk; P O Yates; D Neary; J S Snowden
Journal:  Neuropathol Appl Neurobiol       Date:  1988 May-Jun       Impact factor: 8.090

View more
  17 in total

Review 1.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

Review 2.  The basis for behavioural disturbances in dementia.

Authors:  M M Esiri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

Review 3.  Therapeutics of Neurotransmitters in Alzheimer's Disease.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Neuronal cell loss in the dorsal raphe nucleus and the superior central nucleus in myotonic dystrophy: a clinicopathological correlation.

Authors:  S Ono; F Kanda; K Takahashi; Y Fukuoka; K Jinnai; H Kurisaki; S Mitake; T Inagaki; K Nagao
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

5.  Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele.

Authors:  T Arendt; C Schindler; M K Brückner; K Eschrich; V Bigl; D Zedlick; L Marcova
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

Review 6.  A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders.

Authors:  E Salmon
Journal:  J Neural Transm (Vienna)       Date:  2007-02-19       Impact factor: 3.575

Review 7.  Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.

Authors:  Maria J Ramirez; Mitchell K P Lai; Rosa M Tordera; Paul T Francis
Journal:  Drugs       Date:  2014-05       Impact factor: 9.546

8.  Does Alzheimer's disease begin in the brainstem?

Authors:  G Simic; G Stanic; M Mladinov; N Jovanov-Milosevic; I Kostovic; P R Hof
Journal:  Neuropathol Appl Neurobiol       Date:  2009-08-04       Impact factor: 8.090

9.  Kinetics of serotonin oxidation by heme-Aβ relevant to Alzheimer's disease.

Authors:  Soumya Mukherjee; Manas Seal; Somdatta Ghosh Dey
Journal:  J Biol Inorg Chem       Date:  2014-09-24       Impact factor: 3.358

Review 10.  Monoaminergic neuropathology in Alzheimer's disease.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles R Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude M Wischik; Patrick R Hof
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.